Cytochrome c in cancer therapy and prognosis
Open Access
- 22 December 2022
- journal article
- review article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 42 (12)
- https://doi.org/10.1042/bsr20222171
Abstract
Cytochrome c (cyt c) is an electron transporter of the mitochondrial respiratory chain. Upon permeabilization of the mitochondrial outer membrane, cyt c is released into the cytoplasm, where it triggers the intrinsic pathway of apoptosis. Cytoplasmic cyt c can further reach the bloodstream. Apoptosis inhibition is one of the hallmarks of cancer and its induction in tumors is a widely used therapeutic approach. Apoptosis inhibition and induction correlate with decreased and increased serum levels of cyt c, respectively. The quantification of cyt c in the serum is useful in the monitoring of patient response to chemotherapy, with potential prognosis value. Several highly sensitive biosensors have been developed for the quantification of cyt c levels in human serum. Moreover, the delivery of exogenous cyt c to the cytoplasm of cancer cells is an effective approach for inducing their apoptosis. Similarly, several protein-based and nanoparticle-based systems have been developed for the therapeutic delivery of cyt c to cancer cells. As such, cyt c is a human protein with promising value in cancer prognosis and therapy. In addition, its thermal stability can be extended through PEGylation and ionic liquid storage. These processes could contribute to enhancing its therapeutic exploitation in clinical facilities with limited refrigeration conditions. Here, I discuss these research lines and how their timely conjunction can advance cancer therapy and prognosis.Keywords
This publication has 107 references indexed in Scilit:
- The targeted intracellular delivery of cytochrome C protein to tumors using lipid-apolipoprotein nanoparticlesBiomaterials, 2012
- Composite of CdTe quantum dots and molecularly imprinted polymer as a sensing material for cytochrome cBiosensors and Bioelectronics, 2011
- Cytochrome c as an experimental model proteinMetallomics, 2011
- Nitration of tyrosine 74 prevents human cytochrome c to play a key role in apoptosis signaling by blocking caspase-9 activationBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Cytochrome c Encapsulating Theranostic Nanoparticles: A Novel Bifunctional System for Targeted Delivery of Therapeutic Membrane-Impermeable Proteins to Tumors and Imaging of Cancer TherapyMolecular Pharmaceutics, 2010
- Aptamer-based bio-barcode assay for the detection of cytochrome-c released from apoptotic cellsBiochemical and Biophysical Research Communications, 2010
- Regulation of apoptosis by the redox state of cytochrome cBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2008
- Modification by Homocysteine Thiolactone Affects Redox Status of Cytochrome cBiochemistry, 2007
- The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of ApoptosisScience, 1997
- On cytochrome, a respiratory pigment, common to animals, yeast, and higher plantsProceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character, 1925